Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clevidipine butyrate injection for hypertensive emergency and sub-emergency
ChiCTR2100050577Phase 3Recruiting
- Sponsor
- Beijing Hospital
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of clevidipine in hypertensive emergency and hypertensive urgency (2 arms), sponsored by Beijing Hospital. Primary endpoint: Systolic blood pressure. Started Sep 2021; status: recruiting.
02
Drugs
clevidipine
03
Conditions
hypertensive emergencyhypertensive urgency
Beyond the preview
Go deeper on ChiCTR2100050577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050577.